A Different Perspective on Biosimilar Cost Savings
A new study tags the prevalence of autoimmune diseases at 4.6%, or around 15.2 million people in the US. More than 34% have at least one autoimmune disease and 8% have three autoimmune diseases. Using data from electronic health records, they calculated prevalence figures for dozens of autoimmune disorders. Some of the most notable prevalence … Continue reading A Different Perspective on Biosimilar Cost Savings
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed